The Protein Therapeutics Market: The Science and Business of a Growing Sector

   Single User - $995
   Corporate License - $7,800

Published Jun 1, 2006 | 174 Pages | Pub ID: KLI1187553

The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and business aspects of the protein therapeutics marketplace, including market size and growth, competitive market share, geographical segmentation, top products, and forecasts to 2010 for each of the following individual product areas:
  • Monoclonal Antibodies
  • Erythropoietins
  • Insulin
  • Interferons
  • Growth Factors
  • Interleukins
  • Blood Clotting Factors
  • Tissue Plasminogen Activator
  • Human Growth Hormones
  • Reproductive Hormones
  • Recombinant BMP-2
  • Replacement Enzymes

In addition, the report discusses the major operational and strategic challenges this market presents, including

  • financing
  • pricing and reimbursement,
  • manufacturing
  • marketing, and
  • regulatory issues

Profiles of 21 key competitors—including their products, pipeline, technology platforms, and alliances—round out the comprehensive review.

In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.